Phase 1 Colorectal Cancer Metastatic trials recruiting now

All Colorectal Cancer Metastatic trials, every phase

Other phases for Colorectal Cancer Metastatic

Phase 1 Colorectal Cancer Metastatic trials

• A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
  NCT07244705 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer
  NCT05759728 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study of NILK-2301 in Patients with Locally Advanced or Metastatic Low Tumor Volume (LTV) Colorectal Cancer
  NCT06663839 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer
  NCT07462650 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung
  NCT05611034 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
  NCT07012954 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.